DCDiana Chiosa

Diana Chiosa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Diana Chiosa has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The Prevalence of Rs4149056 Polymorphism of the SLCO1B1 Gene in the Population of the Republic of Moldova

    by Madalina Hincu, Daniela Galea-Abdusa, Alexei Levitchi, Diana Chiosa, Cristina Butovscaia, Ghenadie Curocichin

  • Molecular-Genetic Particularities of the NPC1L1 Gene rs2073547 Polymorphism in the Population of the Republic of Moldova

    by Maria Doni, Daniela Galea-Abdusa, Diana Chiosa, Anastasia Buza, Alexei Levitchi, Ghenadie Curocichin

  • Lipid profile in young people

    by Diana Chiosa, Rodica Ignat, Alexei Levitchi, Ghenadie Curocichin

    Metabolic risk factors for non-communicable chronic diseases develop from an early age, while the clinical manifestations of cardiovascular diseases associated with these risk factors appear later in life. Dyslipidemia is a modifiable risk factor for cardiovascular diseases. The purpose of the study was to evaluate the lipid profile in young people as an early risk factor for cardiovascular disease. Material and methods. The study was conducted on 693 healthy young individuals: 71.4% (495) women and 28.6% (198) men, aged between 17 and 30 years. The measured parameters included total cholesterol, HDL-cholesterol, LDL-cholesterol, and triglycerides, measured using the spectrophotometric method. Non-HDL cholesterol was calculated with the formula: non-HDL-C = TC - HDL-C (mmol/l). Results. A total of 8.2% of young people had total cholesterol levels above the normal threshold (5.0 mmol/l). HDL-cholesterol below the gender-specific threshold values was recorded in 52.5%. Among women, 58.8% had HDL-cholesterol levels ≤ 1.29 mmol/l, and among men, 36.9% had levels below 1.03 mmol/l. Non-HDL cholesterol exceeded the threshold value (3.8 mmol/l) in 5.9% of young people. For 21.4% of participants, LDL-cholesterol was above the threshold (2.59 mmol/l), and 8.2% had triglyceride levels above the normal threshold (1.7 mmol/l). Conclusions. The study demonstrated that over half of the young people (52.5%) had HDL-cholesterol below the genderspecific thresholds. Deviations in the lipid profile increase the atherogenic potential of plasma, highlighting the need for early preventive interventions in this age group.

  • Open Access

    Implementing Package of Essential Non-communicable Disease Interventions in the Republic of Moldova—a feasibility study

    by Tiina Laatikainen, Laura Inglin, Dylan Collins, Angela Ciobanu, Ghenadie Curocichin, Virginia Salaru, Tatiana Zatic, Angela Anisei, Diana Chiosa, Maria Munteanu, et al.

    Background: The aim of this study is to determine the feasibility of implementing and evaluating the World Health Organization Package of Essential Non-communicable Disease Interventions (WHO PEN) approach in primary healthcare in the Republic of Moldova. Methods: According to our published a priori methods, 20 primary care clinics were randomized to 10 intervention and 10 control clinics. The intervention consisted of implementation of adapted WHO PEN guidelines and structured training for health workers; the control clinics continued with usual care. Data were gathered from paper-based patient records in July 2017 and August 2018 resulting in a total of 1174 and 995 patients in intervention and control clinics at baseline and 1329 and 1256 at follow-up. Pre-defined indicators describing assessment of risk factors and total cardiovascular risk, prescribing medications and treatment outcomes were calculated. Differences between baseline and follow-up as well as between intervention and control clinics were calculated using logistic and linear regression models and by assessing interaction effects. Results: Improvements were seen in recording smoking status, activity to measure HbA1c among diabetes patients and achieving control in hypertension treatment. Improvement was also seen in identification of patients with hypertension or diabetes. Less improvement or even deterioration was seen in assessing total risk or prescribing statins for high-risk patients. Conclusions: It is feasible to evaluate the quality and management of patients with non-communicable diseases in low-resource settings from routine data. Modest improvements in risk factor identification and management can be achieved in a relatively short period of time.